Jun. 15, 2024 | ZIPCODE CEO DR. JASON ZHANG TO PRESENT AT 4TH MRNA-BASED THERAPEUTICS SUMMIT IN BOSTON, MA

Boston, MA, USA - Zipcode Bio, a startup specializing in next-generation nucleic acid applications, announces that its co-founder and CEO, Dr. Jason Zhang, will present at the 4th Annual mRNA-Based Therapeutics Summit in Boston, MA. Dr. Zhang will showcase Zipcode Bio’s proprietary RNA medicine platform, addressing solutions to overcome current challenges in RNA-based medicine discovery and development. 

Leveraging extensive RNA expertise and pioneering SHARP technology, Zipcode Bio is dedicated to redefining RNA-based medicines. The presentation will offer insights into cutting-edge research and Zipcode Bio’s commitment to creating revolutionary treatments.

Additionally, Dr. Zhang will chair the session titled "Gearing up for 2025: Licensing, Partnership & Financial Considerations in the Dynamic mRNA Landscape."

The theme of 2024 mRNA-Based Therapeutics Summitis is “Fast-Track Your mRNA-Based Therapeutics & Vaccines From Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications.” For more information, please visit: https://mrnabased-therapeutics.com/

About Zipcode Bio: Zipcode Bio is a biotechnology company specializing in the development of next-generation nucleic acid applications that are accessible, widely distributable, and superior in efficacy and safety. The company's co-founders include Drew Weissman and Dr. Jason Zhang. The scientific strength is based on the co-founders’ deep knowledge in RNA medicine and breakthrough SHARP (Single-component Homogeneous Amphiphilic Routed Particles) technology. Zipcode Bio stands at the forefront of developing revolutionary solutions with the potential to transform patient care. The company has assembled a dynamic team committed to pushing scientific boundaries and developing novel therapeutics to address unmet healthcare needs. The dedication to innovation, precision, and accessibility underscores its mission to improve therapeutic outcomes and contribute to the evolution of global healthcare. 

For more information, please contact jason.zhang@zipcodebio.com